Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Breast Cancer Res Treat ; 202(1): 105-115, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37584882

RESUMEN

PURPOSE: Evaluate the COVID-19 pandemic impact on breast cancer detection method, stage and treatment before, during and after health care restrictions. METHODS: In a retrospective tertiary cancer care center cohort, first primary breast cancer (BC) patients, years 2019-2021, were reviewed (n = 1787). Chi-square statistical comparisons of detection method (patient (PtD)/mammography (MamD), Stage (0-IV) and treatment by pre-pandemic time 1: 2019 + Q1 2020; peak-pandemic time 2: Q2-Q4 2020; pandemic time 3: Q1-Q4 2021 (Q = quarter) periods and logistic regression for odds ratios were used. RESULTS: BC case volume decreased 22% in 2020 (N = 533) (p = .001). MamD declined from 64% pre-pandemic to 58% peak-pandemic, and increased to 71% in 2021 (p < .001). PtD increased from 30 to 36% peak-pandemic and declined to 25% in 2021 (p < .001). Diagnosis of Stage 0/I BC declined peak-pandemic when screening mammography was curtailed due to lock-down mandates but rebounded above pre-pandemic levels in 2021. In adjusted regression, peak-pandemic stage 0/I BC diagnosis decreased 24% (OR = 0.76, 95% CI: 0.60, 0.96, p = .021) and increased 34% in 2021 (OR = 1.34, 95% CI: 1.06, 1.70, p = .014). Peak-pandemic neoadjuvant therapy increased from 33 to 38% (p < .001), primarily for surgical delay cases. CONCLUSIONS: The COVID-19 pandemic restricted health-care access, reduced mammography screening and created surgical delays. During the peak-pandemic time, due to restricted or no access to mammography screening, we observed a decrease in stage 0/I BC by number and proportion. Continued low case numbers represent a need to re-establish screening behavior and staffing.


Asunto(s)
Carcinoma de Mama in situ , Neoplasias de la Mama , COVID-19 , Humanos , Femenino , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/terapia , Mamografía , Estudios Retrospectivos , Pandemias , Detección Precoz del Cáncer , Tamizaje Masivo , Estadificación de Neoplasias , COVID-19/epidemiología , Control de Enfermedades Transmisibles , Prueba de COVID-19
2.
SN Bus Econ ; 3(2): 50, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36714499

RESUMEN

This exploratory study assessed the leadership dispositions of nonprofit leaders, particularly those in executive director roles or higher. The Nonprofit Leadership Dispositions Survey was completed by 99 nonprofit leaders in private human services nonprofits in New York State. Descriptive analysis was used to understand the dominant dispositions. The results indicated that, apart from prudence, participant responses demonstrated evidence of the dispositions and strengths commonly associated with successful leadership. Recommendations for leadership training and development programs, as well as nonprofit organizations, are suggested.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...